Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia (CONVOKE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05838625 |
|
Recruitment Status :
Recruiting
First Posted : May 1, 2023
Last Update Posted : May 13, 2024
|
Sponsor:
Click Therapeutics, Inc.
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Click Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 18, 2025 |
| Estimated Study Completion Date : | July 18, 2025 |